The Chemours Company
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-274.0M | $-29.0M | $-47.0M | $46.0M | $-380.0M | $-5.0M | $-11.0M | $-32.0M |
| Depreciation & Amortization | $80.0M | $79.0M | $81.0M | $80.0M | $91.0M | $88.0M | $74.0M | $73.0M |
| Depreciation | $79.0M | $79.0M | $81.0M | $80.0M | $91.0M | $88.0M | $79.0M | $78.0M |
| Amortization | — | — | — | $1.0M | — | — | — | $1.0M |
| Stock-Based Compensation | $7.0M | $7.0M | $4.0M | $5.0M | $7.0M | $5.0M | $3.0M | $5.0M |
| Net Cash from Operating Activities | $158.0M | $-44.0M | $137.0M | $146.0M | $93.0M | $-112.0M | $138.0M | $139.0M |
| Investing Activities | ||||||||
| Capital Expenditures | $44.0M | $49.0M | $45.0M | $41.0M | $43.0M | $84.0M | $109.0M | $76.0M |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $239.0M | $-44.0M | $-43.0M | $-35.0M | $-42.0M | $-86.0M | $-107.0M | $-75.0M |
| Financing Activities | ||||||||
| Dividends Paid | $13.0M | $13.0M | $15.0M | $13.0M | $13.0M | $37.0M | $36.0M | $38.0M |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $-289.0M | $-19.0M | $-37.0M | $-5.0M | $-27.0M | $-57.0M | $85.0M | $-27.0M |
| Net Change in Cash | $108.0M | $-109.0M | $59.0M | $112.0M | $39.0M | $-249.0M | $97.0M | $47.0M |
| Free Cash Flow | $114.0M | $-93.0M | $92.0M | $105.0M | $50.0M | $-196.0M | $29.0M | $63.0M |